Lyell Immunopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lyell Immunopharma, Inc. has filed 330 SEC EDGAR filings since 20 Mar 2020

SEC filing history

Showing 51-75 of 330 matching filings.

Per page
25
Current page
3
SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93402

SCHEDULE 13G filing

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date
12 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Nov 2025
Reporting date
31 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Oct 2025
Reporting date
27 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Oct 2025
Reporting date
27 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Oct 2025
Reporting date
27 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Aug 2025
Reporting date
20 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Aug 2025
Reporting date
20 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Aug 2025
Reporting date
20 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Aug 2025
Reporting date
20 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93402

SCHEDULE 13G filing

Filing date
19 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .